Marion Mouton

Title: Marion Mouton: Innovator in Papillomavirus Research

Introduction

Marion Mouton is a prominent inventor based in Paris, France. She has made significant contributions to the field of virology, particularly in understanding papillomavirus and its association with cancer. With a total of 2 patents, her work has the potential to impact cancer prognosis and treatment.

Latest Patents

Marion Mouton's latest patents focus on the broad range gene and genotype papillomavirus transcriptome as a biomarker for papillomavirus-associated cancer stages. The inventions provide compositions, kits, and methods for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be utilized for the prognosis of the risk of developing virally-induced cancers. Notably, the ratio (R) between early and late transcripts is indicative of HPV infections that are associated with a higher risk of developing genital neoplasia and cancer.

Career Highlights

Throughout her career, Marion has worked with esteemed institutions such as Institut Pasteur and École Nationale Vétérinaire d'Alfort. Her research has been pivotal in advancing the understanding of viral infections and their implications for human health.

Collaborations

Marion has collaborated with notable colleagues, including Marc Eloit and Nicolas Torno. These partnerships have enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Marion Mouton's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. Her contributions continue to pave the way for advancements in understanding and combating virally-induced cancers.